Literature DB >> 21465655

Nutritional phases in Prader-Willi syndrome.

Jennifer L Miller1, Christy H Lynn, Danielle C Driscoll, Anthony P Goldstone, June-Anne Gold, Virginia Kimonis, Elisabeth Dykens, Merlin G Butler, Jonathan J Shuster, Daniel J Driscoll.   

Abstract

Prader-Willi syndrome (PWS) is a complex neurobehavioral condition which has been classically described as having two nutritional stages: poor feeding, frequently with failure to thrive (FTT) in infancy (Stage 1), followed by hyperphagia leading to obesity in later childhood (Stage 2). We have longitudinally followed the feeding behaviors of individuals with PWS and found a much more gradual and complex progression of the nutritional phases than the traditional two stages described in the literature. Therefore, this study characterizes the growth, metabolic, and laboratory changes associated with the various nutritional phases of PWS in a large cohort of subjects. We have identified a total of seven different nutritional phases, with five main phases and sub-phases in phases 1 and 2. Phase 0 occurs in utero, with decreased fetal movements and growth restriction compared to unaffected siblings. In phase 1 the infant is hypotonic and not obese, with sub-phase 1a characterized by difficulty feeding with or without FTT (ages birth-15 months; median age at completion: 9 months). This phase is followed by sub-phase 1b when the infant grows steadily along a growth curve and weight is increasing at a normal rate (median age of onset: 9 months; age quartiles 5-15 months). Phase 2 is associated with weight gain-in sub-phase 2a the weight increases without a significant change in appetite or caloric intake (median age of onset 2.08 years; age quartiles 20-31 months;), while in sub-phase 2b the weight gain is associated with a concomitant increased interest in food (median age of onset: 4.5 years; quartiles 3-5.25 years). Phase 3 is characterized by hyperphagia, typically accompanied by food-seeking and lack of satiety (median age of onset: 8 years; quartiles 5-13 years). Some adults progress to phase 4 which is when an individual who was previously in phase 3 no longer has an insatiable appetite and is able to feel full. Therefore, the progression of the nutritional phases in PWS is much more complex than previously recognized. Awareness of the various phases will aid researchers in unraveling the pathophysiology of each phase and provide a foundation for developing rational therapies. Counseling parents of newly diagnosed infants with PWS as to what to expect with regard to these nutritional phases may help prevent or slow the early-onset of obesity in this syndrome.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21465655      PMCID: PMC3285445          DOI: 10.1002/ajmg.a.33951

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  27 in total

1.  Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI.

Authors:  N A Shapira; M C Lessig; A G He; G A James; D J Driscoll; Y Liu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

Review 2.  Disease management of Prader-Willi syndrome.

Authors:  Phillip D K Lee
Journal:  Expert Opin Pharmacother       Date:  2002-10       Impact factor: 3.889

3.  Quantification of the methylation status of the PWS/AS imprinted region: comparison of two approaches based on bisulfite sequencing and methylation-sensitive MLPA.

Authors:  Nicola Dikow; Anders Oh Nygren; Jan P Schouten; Carolin Hartmann; Nikola Krämer; Bart Janssen; Johannes Zschocke
Journal:  Mol Cell Probes       Date:  2007-01-12       Impact factor: 2.365

4.  Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects.

Authors:  Merlin G Butler; Mariana F Theodoro; Douglas C Bittel; Joseph E Donnelly
Journal:  Am J Med Genet A       Date:  2007-03-01       Impact factor: 2.802

5.  Neural mechanisms underlying hyperphagia in Prader-Willi syndrome.

Authors:  Laura M Holsen; Jennifer R Zarcone; William M Brooks; Merlin G Butler; Travis I Thompson; Jasjit S Ahluwalia; Nicole L Nollen; Cary R Savage
Journal:  Obesity (Silver Spring)       Date:  2006-06       Impact factor: 5.002

Review 6.  Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology.

Authors:  Douglas C Bittel; Merlin G Butler
Journal:  Expert Rev Mol Med       Date:  2005-07-25       Impact factor: 5.600

7.  Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Merlin G Butler
Journal:  Genet Test       Date:  2007

Review 8.  Prader-Willi syndrome: advances in genetics, pathophysiology and treatment.

Authors:  Anthony P Goldstone
Journal:  Trends Endocrinol Metab       Date:  2004 Jan-Feb       Impact factor: 12.015

9.  Enhanced activation of reward mediating prefrontal regions in response to food stimuli in Prader-Willi syndrome.

Authors:  Jennifer L Miller; G Andrew James; Anthony P Goldstone; Jessica A Couch; Guojun He; Daniel J Driscoll; Yijun Liu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-08       Impact factor: 10.154

10.  Sylvian fissure morphology in Prader-Willi syndrome and early-onset morbid obesity.

Authors:  Jennifer L Miller; Jessica A Couch; Christiana M Leonard; Krista Schwenk; Stephen D Towler; Jonathan Shuster; Anthony P Goldstone; Guojun He; Daniel J Driscoll; Yijun Liu
Journal:  Genet Med       Date:  2007-08       Impact factor: 8.822

View more
  129 in total

Review 1.  Review of Prader-Willi syndrome: the endocrine approach.

Authors:  Ryan Heksch; Manmohan Kamboj; Kathryn Anglin; Kathryn Obrynba
Journal:  Transl Pediatr       Date:  2017-10

2.  Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment.

Authors:  T Cadoudal; M Buléon; C Sengenès; G Diene; F Desneulin; C Molinas; S Eddiry; F Conte-Auriol; D Daviaud; P G P Martin; A Bouloumié; J-P Salles; M Tauber; P Valet
Journal:  Int J Obes (Lond)       Date:  2014-01-10       Impact factor: 5.095

Review 3.  Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.

Authors:  Merlin G Butler; Jennifer L Miller; Janice L Forster
Journal:  Curr Pediatr Rev       Date:  2019

4.  Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors.

Authors:  Marta Pace; Matteo Falappa; Andrea Freschi; Edoardo Balzani; Chiara Berteotti; Viviana Lo Martire; Fatemeh Kaveh; Eivind Hovig; Giovanna Zoccoli; Roberto Amici; Matteo Cerri; Alfonso Urbanucci; Valter Tucci
Journal:  JCI Insight       Date:  2020-06-18

5.  Hyperactive hypothalamus, motivated and non-distractible chronic overeating in ADAR2 transgenic mice.

Authors:  A Akubuiro; M Bridget Zimmerman; L L Boles Ponto; S A Walsh; J Sunderland; L McCormick; M Singh
Journal:  Genes Brain Behav       Date:  2013-02-18       Impact factor: 3.449

6.  Growth charts for non-growth hormone treated Prader-Willi syndrome.

Authors:  Merlin G Butler; Jaehoon Lee; Ann M Manzardo; June-Anne Gold; Jennifer L Miller; Virginia Kimonis; Daniel J Driscoll
Journal:  Pediatrics       Date:  2014-12-08       Impact factor: 7.124

7.  EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.

Authors:  M G Butler; T A Nelson; D J Driscoll; A M Manzardo
Journal:  J Rare Disord       Date:  2015-09

8.  Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia.

Authors:  Steven B Heymsfield; Nicole M Avena; Leslie Baier; Phillip Brantley; George A Bray; Lisa C Burnett; Merlin G Butler; Daniel J Driscoll; Dieter Egli; Joel Elmquist; Janice L Forster; Anthony P Goldstone; Linda M Gourash; Frank L Greenway; Joan C Han; James G Kane; Rudolph L Leibel; Ruth J F Loos; Ann O Scheimann; Christian L Roth; Randy J Seeley; Val Sheffield; Maïthé Tauber; Christian Vaisse; Liheng Wang; Robert A Waterland; Rachel Wevrick; Jack A Yanovski; Andrew R Zinn
Journal:  Obesity (Silver Spring)       Date:  2014-02       Impact factor: 5.002

9.  A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome.

Authors:  J L Miller; C H Lynn; J Shuster; D J Driscoll
Journal:  J Hum Nutr Diet       Date:  2012-10-18       Impact factor: 3.089

10.  Hypothalamic loss of Snord116 and Prader-Willi syndrome hyperphagia: the buck stops here?

Authors:  Juan A Rodriguez; Jeffrey M Zigman
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.